Cargando…
Relationships between developmental strategies for additional indications and price revisions for anticancer drugs in Japan
BACKGROUND: The relationships between developmental strategies for additional indications and drug price revisions have not been thoroughly studied. Here, we investigated the price revisions for anticancer drugs approved in Japan. METHODS: The study was based on published information on anticancer d...
Autores principales: | Maeda, Hideki, Okabe, Ayano, Sakakura, Kenichi, Ng, Daniel Bin, Akazawa, Manabu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665599/ https://www.ncbi.nlm.nih.gov/pubmed/34895223 http://dx.doi.org/10.1186/s12913-021-07360-w |
Ejemplares similares
-
Correlation of Anticancer Drug Prices with Outcomes of Overall Survival and Progression-Free Survival in Clinical Trials in Japan
por: Okabe, Ayano, et al.
Publicado: (2023) -
Effects of medical service fee revision on reducing irrational psychotropic polypharmacy in Japan: an interrupted time-series analysis
por: Okada, Yusuke, et al.
Publicado: (2021) -
Price Revision Formulae
Publicado: (1976) -
Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
por: Zhang, Yichen, et al.
Publicado: (2022) -
Evaluation of Price Revision Formulae for Adjudication Purposes
Publicado: (1982)